N (248) | Mean ± SD | Median (25th-75th Quarter) | ||
---|---|---|---|---|
Age | 22.72 ± 4.07 | |||
Anthropometric Measurements | ||||
Weight (kg) | 77.30 ± 17.81 | |||
Height (cm) | 162.54 ± 4.95 | |||
Waist Circumference (cm) | 83.91 ± 12.80 | |||
Hip Circumference (cm) | 109.26 ± 15.01 | |||
BMI (kg/m2) | 29.24 ± 6.72 | |||
WHtR | 0.52 ± 0.08 | |||
BAI (%) | 34.85 ± 7.88 | |||
BRI | 3.81 ± 1.59 | |||
WHR | 0.76 (0.74–0.78) | |||
VAI | 3.85 (2.65–5.97) | |||
LAP | 5325 (3074–7176) | |||
ABSI | 0.07 (0.07–0.07) | |||
Biochemical Parameters | ||||
120 min Glucose (mg/dL) | 141.97 ± 23.35 | |||
60 min Insulin (mU/L) | 111.31 ± 19.66 | |||
HbA1c (%) | 5.39 ± 0.59 | |||
Total Cholesterol (mg/dL) | 171.19 ± 30.22 | |||
HDL Cholesterol (mg/dL) | 55.68 ± 14.43 | |||
LDL Cholesterol (mg/dL) | 95.92 ± 25.95 | |||
Fasting Glucose (mg/dL) | 89 (84–95) | |||
Fasting Insulin (mU/L) | 12.30 (8.05–15.64) | |||
60 min Glucose (mg/dL) | 89 (85–94) | |||
Triglycerides (mg/dL) | 94.50 (71.50–131.00) | |||
HOMA-IR Index | 47.36 (32.72–67.21) | |||
Atherogenic Indexes | ||||
Castelli’s Risk Index-I | 3.25 ± 0.90 | |||
Castelli’s Risk Index-II | 1.86 ± 0.74 | |||
AIP | 0.26 ± 0.24 | |||
AC | 2.25 ± 0.90 | |||
METS-IR | 41.75 ± 11.03 | |||
TyG Index | 8.38 ± 0.48 | |||
TyG-BMI | 245.54 ± 60.78 | |||
TyG-Waist Circumference Index | 917.80 ± 148.37 | |||
LCI | 28481.54 (15771.24–47946.00) | |||
TG/HDL-C | 1.74 (1.16–2.62) |